Bottom Line ApoB is closer to the causal biology of atherosclerosis than LDL-C
no consistent signal for organ toxicity or long-term harm across decades of use Special Populations: Clinical experience exists in elderly patients with dementia and stroke patients, populations where safety data is particularly valuable IV Administration Considerations: Requires clinical administration setting for intravenous dosing, which limits convenience but ensures medical oversight Dihexa: Unknown Human Safety Profile Dihexa has never been administered to humans in any controlled setting, creating a complete absence of human safety data: No Human Pharmacokinetics: Absorption, distribution, metabolism, and excretion parameters are unknown in humans Theoretical c-Met Oncogenesis Concern: The c-Met/HGF pathway is implicated in cancer progression aberrant c-Met signaling promotes tumor growth, metastasis, and angiogenesis in multiple cancer types
Each component contributes uniquely to anabolic and recovery mechanisms
Voir le profil Rfrences Note : les liens hypertextes menant vers d'autres sites ne sont pas mis jour de faon continue
For research purposes, it must be reconstituted with Bacteriostatic Water
L-Carnitine supplementation is most advantageous for those with a deficiency
